focus -WSS

focus

author：comprehensive 2025-09-29 20:50:38 - browse：821

Principal Deputy FDA Commissioner Janet Woodcock Stefani Reynolds/The New York Times via AP

WASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the Food and Drug Administration after helping steer the agency through an historic period of medical advances during nearly four decades in key leadership positions, she confirmed to STAT Thursday.

Woodcock, a doctor with a chemistry degree, joined FDA in 1986 at its biologics center, where she oversaw the approval of the first biotechnology-based treatments for multiple sclerosis and cystic fibrosis. In 1994, she was named director of the drug center, where she played a key role in guiding some of the most impactful changes to the regulation of medicine, according to Trump administration FDA Commissioner Scott Gottlieb.

Woodcock envisioned that antibody drugs would become a backbone of therapy and created a more predictable regulatory path for their review and approval, Gottlieb said. She presided over a major expansion and modernization of the generic drug program, standardizing reviews in a way that allowed the industry to become safer and more robust, and crafted the reform of over-the-counter drug reviews.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Blood tests recalled over risk of missed heart attack diagnosis

hotspot

WSS

In diabetes hearing, Sanders takes on a new foe: food makers

Celiac disease study examines precisely how gluten triggers injury

Americans' trust in science, scientist continues decline: Report

FDA needs staff influx to meet gene therapy needs, Marks says

Celiac disease study examines precisely how gluten triggers injury

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

knowledge

focus

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

Pharma patents targeted by Biden in move to slash drug prices

Continuity nursing helped my family in our darkest PICU moments

Roche to buy Carmot Therapeutics, developer of obesity drugs

ChatGPT in medicine: STAT answers readers' burning questions

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Alkermes shareholders re

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Bright Health sells Medicare Advantage business to Molina

SCOTUS to consider access to abortion pill mifepristone

entertainment

In diabetes hearing, Sanders takes on a new foe: food makers

What causes an itch? Researchers may have solved the mystery

Congress: Eradicate hepatitis C and reduce the deficit

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Radiology is caught between AI's potential and concern for patients

hotspot

hotspot

hotspot

Wikipedia